Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence
Journal of Radiation Research · 24.07.2026 · 67 (4) · 525-537
DOI: 10.1093/jrr/rrag048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, online erschienen am 15.07.2026. Verfasst von Lixin Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Cellular Senescence, Oligopeptides, Mitochondria. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIGMS.
Abstract (Originalsprache)
Exposure to ionizing radiation, such as from radiation therapy or accidental radiation exposure can have adverse effects on the heart. While radiation injury in the heart may include cardiomyocyte senescence, there are no available strategies to prevent this phenomenon. This study evaluated the effects of the mitochondrial-targeted peptide SS-31 (elamipretide) on radiation-induced cell senescence in cardiomyoblast H9C2 cells and human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs). Exposure to γ-radiation at doses of 2, 5, and 10 Gy inhibited H9C2 cell proliferation in a dose-dependent manner, and induced senescence-associated beta-galactosidase (SA-β-gal) staining, a gold standard of cell senescence. Treatment with SS-31 (1 μM) for 7 days reduced SA-β-gal positive staining from 67% to 38% in H9C2 cells under 10 Gy radiation. SS-31 also prevented increases in the expression of p16 and p21, two well-accepted senescence markers, in irradiated H9C2 cells and hiPSC-CMs. SS-31 decreased the canonical senescence-associated secretory phenotype markers TNF-α, IL-6, and IL-1β. SS-31 also reversed the BAX/bcl-2 ratio, a marker of mitochondrial-related apoptosis. Moreover, SS-31 mitigated mitochondrial production of reactive oxygen species. Interestingly, we found that a dose of 10 Gy increased mitochondrial respiration, and SS-31 reversed this elevation. This study suggests that SS-31 is a promising compound that may prevent radiation-induced cardiomyocyte senescence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA.
- Department of Medical Genetics & Molecular Biochemistry, Lewis Katz School of Medicine, Temple University, 3440 N Broad St, Kresge Hall, Philadelphia, PA 19140, USA.
- Division of Radiation Health, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA.
- Department of Pediatrics and Department of Geriatrics, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA.
- Department of Biology, Rutgers University-Camden, Joint Health Sciences Center, 201 South Broadway, Camden, NJ 08103, USA.
ORCID-Profile: Elisabet Børsheim, Huiliang Zhang
Förderung
- NIGMS NIH HHS
- NIGMS
Zitieren
APA
Xie, L., Wu, J., Fan, J., Krager, K. J., Aykin-Burns, N., Li, S., Børsheim, E., Qi, X., Boerma, M., & Zhang, H. (2026). Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence. Journal of Radiation Research, 67(4), 525-537. https://doi.org/10.1093/jrr/rrag048
Vancouver
Xie L, Wu J, Fan J, Krager KJ, Aykin-Burns N, Li S, et al. Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence. Journal of Radiation Research. 2026;67(4):525-537. doi:10.1093/jrr/rrag048
BibTeX
@article{Xie2026,
author = {Xie, Lixin and Wu, Jinzi and Fan, Jiaojiao and Krager, Kimberly J and Aykin-Burns, Nukhet and Li, Songlin and Børsheim, Elisabet and Qi, Xingyun and Boerma, Marjan and Zhang, Huiliang},
title = {Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence},
journal = {Journal of Radiation Research},
year = {2026},
volume = {67},
number = {4},
pages = {525--537},
doi = {10.1093/jrr/rrag048}
}
EUVIMED